Cartesian Therapeutics Inc (RNAC)
SBC to Revenue
0.00%
Quarterly · Period ending:
RNAC SBC to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
RNAC Quarterly SBC/Revenue (29.21% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
RNAC sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 0% | |
| 3,106.4103% | |
| 226.3992% | |
| 573.0088% | |
| 1,100.3356% | |
| 228% | |
| -245.7181% | |
| 437.9845% | |
| 4.7571% | |
| 24.5034% | |
| 210.4767% | |
| 35.4297% | |
| 72.0709% | |
| 38.3294% | |
| 13.5517% | |
| 12.5592% | |
| 9.0749% | |
| 8.0973% | |
| 7.5258% | |
| 7.7947% | |
| 9.0678% | |
| 16.1086% | |
| 10.3422% | |
| 27.895% | |
| 0% | |
| 0% | |
| 21.4457% | |
| 0% | |
| 9,623.0769% | |
| 11,800% | |
| 198.2281% | |
| 0% | |
| 0% | |
| 0% | |
| 7,111.7647% | |
| 4,866.6667% | |
| 3,326.9231% | |
| 505.8394% | |
| 26.2799% | |
| 60.3053% | |
| 18.1953% | |
| 13.5057% | |
| 11.9963% | |
| 15.6814% | |
| 25.4854% | |
| 29.207% |